Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Celebrate the Annual Celebrity Steak-Out! Join us for an evening of food, fun and philanthropy at Celebrity Steak-Out presented by Brotherton Cadillac Buick GMC. A silent auction and cocktail hour ...

The Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE), one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort between Fred Hutch and ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

The Pacific Northwest (PNW) Prostate Cancer SPORE aims to focus on finding molecular and other factors associated with the risk of prostate cancer recurrence and progression as well as its response – ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.